Tomer Gold
Hoofd Techniek/Wetenschap/O&O bij Dexcel Pharma Technologies Ltd.
Profiel
Tomer Gold is currently the Vice President-Research & Development at Dexcel Pharma Technologies Ltd.
He previously worked as an Independent Director at Cynapsus Therapeutics, Inc. from 2014 to 2016.
Mr. Gold received his undergraduate and graduate degrees from Technion-Israel Institute of Technology.
Actieve functies van Tomer Gold
| Bedrijven | Functie | Begin |
|---|---|---|
Dexcel Pharma Technologies Ltd.
 Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 |
Eerdere bekende functies van Tomer Gold
| Bedrijven | Functie | Einde |
|---|---|---|
| CYNAPSUS THERAPEUTICS INC | Directeur/Bestuurslid | 21-10-2016 |
Opleiding van Tomer Gold
| Technion-Israel Institute of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel. | Health Technology |
